- Investing Ideas
- Spanish Pharmaceuticals & Biotech Healthy potentially undervalued
Spanish Pharmaceuticals & Biotech Healthy potentially undervalued
Results
3
Companies which are potentially undervalued and in an acceptable financial position.
3 companies
Faes Farma
Market Cap: €1.4b
Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally.
FAE
€4.70
7D
3.2%
1Y
9.2%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€60.10
7D
2.6%
1Y
15.2%
Pharma Mar
Market Cap: €1.7b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€101.50
7D
5.6%
1Y
16.2%